Sofinnova Investments, Inc. Adicet Bio, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$13.43 - $18.74 $354,740 - $494,998	-26,414 Reduced 5.1%	491,965 $7 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $1.05 Million - $2.12 Million	102,090 Added 24.52%	518,379 $7.57 Million
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $1.21 Million - $2.1 Million	105,301 Added 33.86%	416,289 $8.31 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $2.29 Million - $5.44 Million	310,988 New	310,988 $5.44 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.